CAS NO: 112809-51-5
letrozole Content: 99%
Molecular Formula: C17H11N5 letrozole
Letrozole is an oral non-steroidal inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
letrozole prevents the aromatase from producing estrogens by competitive, reversible binding to the heme of its cytochrome p450 unit, the action is specific,and letrozol does not reduce
production of mineralo-or corticosteroids.
USES: pharmaceutical intermediates, after menopause advanced breast cancer, more for anti-estrogen therapy failed two line therapy.
we supply Boldenone,Drostanolone Enanthate,Drostanolone propionate,Tadalafil,Dianabol ,Oxandrolone,Oxymetholone,Stanozolol,Methenolone Acetate,Methenolone Enanthate,Testosterone
enanthate,Testosterone propionate,Nandrolone Decanoate,Trenbolone Acetate,Trenbolone Enanthate.
Tel:00862781331422
Fax:00862781331422
Cel:+8615337164625
Skyepe:leslie(at)carphetin(dot)com
Email:leslie(at)carphetin(dot)com
Post by leslie lee Chemicals @2015-06-10 08:20:26